Cipla stock gains; US FDA inspection concludes with zero observations
- Hot Stocks
admin
- 0
- 1 minute read
Cipla has completed the transfer of its generics business #39;as a going concern on a slump sale basis to Cipla Pharma and Life Sciences Limited#39;, the company told bourses
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1137356798-07a2e94fdba4405e80e24e125ae9fb74.jpg "<div>The Economics of Mexico's Middle Class</div>")